NCT01880268

Brief Summary

This study integrates the wireless EEG system with an ordinary rehabilitation device (an upper limb ergometer, "arm bike") used in the Department of Physical Medicine and Rehabilitation at our hospital for a brain-computer-interface (BCI)-controlled neurorehabilitation device, and aims to test the effectiveness of this device. We hypothesize that, the coupling of electroencephalographic signals related with initiation of limb movements with a mechanical device which assists the intended movement is effective to facilitate motor recovery in patients with brain lesion. We propose to enroll 20 patients with cerebrovascular accident (CVA) (4-24 months after the onset of CVA) and the patients will be randomly assigned to experimental (using BCI controlled device and undergoing standard rehabilitation) and control groups (undergoing standard rehabilitation alone). To compare the rehabilitation results among these groups, we propose to use various assessment tools including clinical evaluation (Fugl-Meyer assessment, Modified Ashworth scale, Motor Activity Log, Functional Independence Measure) as well as functional Magnetic Resonance Imaging (fMRI) and Diffusion Tensor Imaging (DTI) before, immediate and 2 months after completion of the training protocol.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2013

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 18, 2013

Completed
13 days until next milestone

Study Start

First participant enrolled

July 1, 2013

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

January 23, 2017

Status Verified

January 1, 2017

Enrollment Period

4.4 years

First QC Date

June 14, 2013

Last Update Submit

January 20, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • upper limb function as measured by Fugl-Meyer Assessment

    upper limb function as measured by Fugl-Meyer Assessment (Upper extremity motor score, arm score, wrist and hand score)

    1st assement: 1 week prior to therapy,

Secondary Outcomes (4)

  • Motor Activity Log

    1st assement: 1 week prior to therapy,

  • Functional Independence Measure

    1st assement: 1 week prior to therapy,

  • functional magnetic resonance imaging

    1st assement: 1 week prior to therapy,

  • Diffusion Tensor Imaging

    1st assement: 1 week prior to therapy,

Study Arms (2)

BCI-then-Standard Rehab Group (Group A)

EXPERIMENTAL

Participants will take 8 weeks of BCI rehabilitation first (3 rehabilitation sessions each week, a total of 24 sessions); participants receive 100 minutes of standard rehabilitation and 20 minutes BCI rehabilitation training using BCI-controlled neurorehabilitation device during each session. After finishing 8 weeks of BCI rehabilitation, participants will take 3 standard rehabilitation therapy sessions (for 2 hours) each week for 8 weeks (a total of 24 sessions)

Device: BCI-controlled neurorehabilitation deviceBehavioral: Standard rehabilitation therapy

Standard-then-BCI Rehab Group (Group B)

EXPERIMENTAL

Participants will take 8 weeks of standard rehabilitation therapy first (3 sessions per week, 2 hours for each session, a total of 24 sessions). After that, participants will take 8 weeks of BCI rehabilitation (3 rehabilitation sessions each week, a total of 24 sessions); participants receive 100 minutes of standard rehabilitation and 20 minutes BCI rehabilitation training using BCI-controlled neurorehabilitation device during each session.

Device: BCI-controlled neurorehabilitation deviceBehavioral: Standard rehabilitation therapy

Interventions

Brain computer interface (BCI) -controlled neurorehabilitation device uses a participant's EEG to control with movements of an ordinary rehabilitation device (an upper limb ergometry, "arm bike")

BCI-then-Standard Rehab Group (Group A)Standard-then-BCI Rehab Group (Group B)

Standard rehabilitation therapy for patient with stroke includes 1 hour of physical therapy and 1 hour of occupational therapy

BCI-then-Standard Rehab Group (Group A)Standard-then-BCI Rehab Group (Group B)

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • cerebrovascular accident (CVA) for the first time
  • between 4 months and 2 years after onset of CVA
  • diagnosis of CVA proved by brain computed tomography or magnetic resonance imaging (MRI)
  • motor status of CVA-affected proximal upper extremity: equals to or better than Brunnström stage IV
  • ability to understand verbal commands and cooperate with test procedures

You may not qualify if:

  • pain in the CVA-affected upper extremity, which adversely influences function
  • severe joint contracture in the CVA-affected upper extremity
  • strong spasticity (Modified Ashworth scale \>3)
  • poorly controlled epilepsy
  • inability to undergo MRI for medical or other reasons

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

China Medical University Hospial

Taichung, Taiwan, 404, Taiwan

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Nai-Hsin Meng, MD

    Director, Department of Physical Medicine and Rehabilitation, China Medical University Hospital, Taichung, Taiwan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Nai-Hsin Meng, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Department of Physical Medicine and Rehabilitation

Study Record Dates

First Submitted

June 14, 2013

First Posted

June 18, 2013

Study Start

July 1, 2013

Primary Completion

December 1, 2017

Study Completion

December 1, 2017

Last Updated

January 23, 2017

Record last verified: 2017-01

Locations